Latest CAMBIA Stories
With more than 15 years of leadership experience in entrepreneurship and health care technology, Ben Albert will focus on accelerating Cambia's investments. Portland,
Leading nonprofit health insurance company chooses Relias trainings to further industry leading palliative care program. Cary, NC (PRWEB) April 23, 2015
Chip Parkinson as President of OmedaRx will focus on positioning Cambia's pharmacy operations for continuing strategic growth Portland, Oregon (PRWEB) April
Cambia Health Leads with Participation from GE Ventures, Ziegler-LinkAge Longevity Fund, Arsenal Venture Partners, and Generator Ventures CHICAGO, Jan.
BRIDGEWATER, N.J., June 8 /PRNewswire/ -- Nautilus Neurosciences, Inc., a neurology-focused specialty pharmaceutical company headquartered in New Jersey, announced today that CAMBIA(TM) (diclofenac potassium for oral solution) is now available in the United States for the acute treatment of migraine with or without aura.